Loading
·
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.